ROBUST FRACTIONAL SATURATION DETERMINATION
    11.
    发明申请

    公开(公告)号:US20180116575A1

    公开(公告)日:2018-05-03

    申请号:US15795007

    申请日:2017-10-26

    CPC classification number: A61B5/14551 A61B5/7203 A61B5/7221

    Abstract: The present disclosure describes the derivation and measurement of a fractional oxygen saturation measurement. In one embodiment, a system includes an optical sensor and a processor. The optical sensor can emit light of multiple wavelengths directed at a measurement site of tissue of a patient, detect the light after attenuation by the tissue, and produce a signal representative of the detected light after attenuation. The processor can receive the signal representative of the detected light after attenuation and determine, using the signal, a fractional oxygen saturation measurement based on two or more different measures of fractional oxygen saturation.

    Multi-site noninvasive measurement of a physiological parameter

    公开(公告)号:US12232888B2

    公开(公告)日:2025-02-25

    申请号:US18048365

    申请日:2022-10-20

    Abstract: A patient monitor can noninvasively measure a physiological parameter using sensor data from different measurement sites on a patient. The patient monitor can combine all sensor data from different measurement sites into a raw or minimally processed data form to generate a single, robust measurement of the physiological parameter. An optical sensor of a patient monitor can include multiple photodetectors each configured to generate a signal when detecting light attenuated by the patient's tissue. A measurement of a physiological parameter can be determined based on at least in part on the multiple signals from the multiple photodetectors.

    NOSE SENSOR
    16.
    发明申请

    公开(公告)号:US20210169418A1

    公开(公告)日:2021-06-10

    申请号:US17079028

    申请日:2020-10-23

    Abstract: A patient monitor can noninvasively measure a physiological parameter using sensor data from a nose sensor configured to be secured to a nose of the patient. The nose sensor can include an emitter and a detector. The detector is configured to generate a signal when detecting light attenuated by the nose tissue of the patient. An output measurement of the physiological parameter can be determined based on the signals generated by the detector. The nose sensor can include an inner prong and an outer prong to assist the nose sensor in securing to a patient's nose. The detector can be coupled to an inner post of the inner prong and can be configured to secure to an interior or exterior portion of the patient's nose.

    Nose sensor
    17.
    发明授权

    公开(公告)号:US10849554B2

    公开(公告)日:2020-12-01

    申请号:US15955500

    申请日:2018-04-17

    Abstract: A patient monitor can noninvasively measure a physiological parameter using sensor data from a nose sensor configured to be secured to a nose of the patient. The nose sensor can include an emitter and a detector. The detector is configured to generate a signal when detecting light attenuated by the nose tissue of the patient. An output measurement of the physiological parameter can be determined based on the signals generated by the detector. The nose sensor can include an inner prong and an outer prong to assist the nose sensor in securing to a patient's nose. The detector can be coupled to an inner post of the inner prong and can be configured to secure to an interior or exterior portion of the patient's nose.

    Robust fractional saturation determination

    公开(公告)号:US12226206B2

    公开(公告)日:2025-02-18

    申请号:US17377170

    申请日:2021-07-15

    Abstract: The present disclosure describes the derivation and measurement of a fractional oxygen saturation measurement. In one embodiment, a system includes an optical sensor and a processor. The optical sensor can emit light of multiple wavelengths directed at a measurement site of tissue of a patient, detect the light after attenuation by the tissue, and produce a signal representative of the detected light after attenuation. The processor can receive the signal representative of the detected light after attenuation and determine, using the signal, a fractional oxygen saturation measurement based on two or more different measures of fractional oxygen saturation.

Patent Agency Ranking